AstraZeneca UK Limited

Horizon Place, 600 Capability Green, Luton, Bedfordshire, LU1 3LU
Telephone: +44 (0)1582 836 000
Fax: +44 (0)1582 838 000
Medical Information Direct Line: +44 (0)1582 836 836
Medical Information e-mail: medical.informationuk@astrazeneca.com
Customer Care direct line: +44 (0)1582 837 837
Medical Information Fax: +44 (0)1582 838 003

Patient Information Leaflet last updated on the eMC: 19/11/2009
PIL Entocort CR 3mg Capsules

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 19/11/2009 and displayed until Current
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 05/08/2009 and displayed until 19/11/2009
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
Updated on 25/06/2008 and displayed until 05/08/2009
Reasons for adding or updating:
  • Change due to user-testing of patient information
Updated on 26/07/2006 and displayed until 25/06/2008
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about missed dose
  • Change to drug interactions
  • Change to date of revision
Updated on 25/07/2006 and displayed until 26/07/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about missed dose
  • Change to drug interactions
  • Change to date of revision
Updated on 12/05/2006 and displayed until 25/07/2006
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change of contra-indications
  • Change to instructions about missed dose
  • Change to drug interactions
  • Change to date of revision
Updated on 03/11/2004 and displayed until 12/05/2006
Reasons for adding or updating:
  • Change to date of revision
Updated on 04/09/2002 and displayed until 03/11/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 17/06/2002 and displayed until 04/09/2002
Reasons for adding or updating:
  • Update to PIL
Updated on 30/05/2002 and displayed until 17/06/2002
Reasons for adding or updating:
  • New PIL for eMC ie a PIL for an existing product but new to the eMC

Active Ingredients/Generics

 
   budesonide